Norges Bank acquired a new stake in Gilead Sciences, while Boston Partners also bought shares, all filed with the SEC.

The entities involved

• Gilead Sciences →

  American company

  • Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.Sun 22:40
  • A pilot program is underway involving the federal government, Benue State, and Gilead Sciences, with the state participating in the drug supply management.Sat 01:51
• Norges Bank →

  central bank of Norway

  • Norges Bank bought a new position in Qualcomm shares, coinciding with buy ratings and price targets from TD Cowen, reported by MarketBeat.Mon 06:47
  • Norges Bank acquired a new stake in Brunswick Corporation.Mon 04:46
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Norges Bank purchased a new position in shares of Boston Scientific.Aug 17
• Norges Bank bought a new stake in Cardinal Health and filed the required disclosure with the SEC on August 27, 2026.Aug 27
• Norges Bank purchased a new stake in Salesforce.Sep 5
• Norges Bank bought shares of UnitedHealth Group, prompting the company to file required reports with the SEC.Aug 1
• Norges Bank purchased a new stake in Microsoft stock on June 6, 2026.Jun 10